OrbiMed Advisors »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $41M 2.7M 15.13
2025-06-30 $31M 2.8M 11.27

More positions owned by OrbiMed Advisors

Boston Scientific Corporation (BSX)
Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)
Argenx Se Sponsored Adr (ARGX)
Sionna Therapeutics (SION)
Upstream Bio (UPB)
Disc Medicine (IRON)
Caris Life Sciences (CAI)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

FMR
Morgan Stanley
Sb Investment Advisers
BlackRock
Vanguard Group
QVT Financial
Viking Global Investors
Rubric Capital Management
State Street Corporation
Two Seas Capital
Patient Square Capital
Dimensional Fund Advisors
Geode Capital Management
Perceptive Advisors
Adage Capital Partners GP

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017